• U.K.
    • USA
    • GER
    • CHI
    • FRA
    • PT(BR)

Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare

  • U.K.
    • USA
    • GER
    • CHI
    • FRA
    • PT(BR)
  • Resources
    • FAQs
    • Quality Certificates
    • White Papers
    • Bioquell QuAD Data Portal
    • Training Portal
    • Material Safety Data Sheets
  • News & Events
  • About
    • Company
    • Company Locations
    • Distributors
    • Careers
    • Investors
  • Pharmaceuticals & Life Sciences
    • Our Technology for Life Sciences
    • Why Bioquell Technology?
    • Systems for Life Sciences
    • Rapid Bio Decontamination Service
    • Validation
  • Healthcare
    • Why Bioquell Technology?
    • Our Technology for Healthcare
    • Bioquell Compared to UV
    • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
    • Systems for Healthcare
    • Services for Healthcare
  • Rapid Bio Decontamination Service
    • For Life Sciences
    • For Healthcare
    • RBDS Applications
      • Remediation Needs
      • Emergency Response
      • Disaster Recovery Plan
      • Commissioning
      • End of Campaign and Facility Restart
      • Lab and Research Spaces
      • Hospital Related Contamination Events
  • Qube Isolator
  • Contact
    • Pharmaceuticals & Life Sciences
      • Our Technology for Life Sciences
      • Why Bioquell Technology?
      • Systems for Life Sciences
      • Rapid Bio Decontamination Service
      • Validation
    • Healthcare
      • Why Bioquell Technology?
      • Our Technology for Healthcare
      • Bioquell Compared to UV
      • Aerosolised Versus Bioquell’s Hydrogen Peroxide Vapour
      • Systems for Healthcare
      • Services for Healthcare
    • Rapid Bio Decontamination Service
      • For Life Sciences
      • For Healthcare
      • RBDS Applications
        • Remediation Needs
        • Emergency Response
        • Disaster Recovery Plan
        • Commissioning
        • End of Campaign and Facility Restart
        • Lab and Research Spaces
        • Hospital Related Contamination Events
    • Qube Isolator
    • Contact

News

Formaldehyde – what does the future hold?

January 2019

John Chewins, Director, Scientific & Regulatory Affairs – Bioquell As most laboratory professionals will be aware, on the 1st January 2016, the EU officially adopted the reclassification of Formaldehyde, under the CLP (Classification, Labelling and Packaging) Regulations EC 1272/2008, as a Class 1B Carcinogen and Class 2 Mutagen. In simple terms, a Class 1B identification […]

Read More

Bioquell Highlights Advanced Bio-decontamination Solutions for the Pharmaceutical Industry

November 2018

BIOQUELL HIGHLIGHTS ADVANCED BIO-DECONTAMINATION SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY Bioquell (www.bioquell.com) is highlighting its wide range of advanced bio-decontamination solutions for the pharmaceutical industry. Bioquell’s Rapid Bio-decontamination Service (RBDS) is available on a 24/7 basis and reacts quickly to eliminate pathogens, stop escalated incidents and handle emergency response situations. The Bioquell Z-2 incorporates a Hydrogen […]

Read More

Bioquell to Highlight Bio-Decontamination Solutions for Reduced Risk of Healthcare-Associated Infections

August 2018

Latest developments utilising Bioquell Hydrogen Peroxide Vapour help avoid unexpected, costly incidents, limit the impact of an outbreak & ensure patient safety Bioquell – one of the leading global experts in reducing the risk of bio-contamination in the healthcare industry – will be highlighting its range of bespoke solutions for eliminating healthcare-associated infections (HAIs). The […]

Read More

Reducing the Risk of Bio-contamination in Gene, Cell and CAR-T Therapy

August 2018

Bioquell’s Dr Rolf Hansen examines how the latest isolator systems create aseptic working conditions for reducing risk and keeping gene, cell and CAR-T therapies efficient, compliant and accurate, whilst also supporting biologics manufacturing expansion and enabling more patients to be treated at the same time. Gene, cell and CAR-T therapies are the latest techniques that […]

Read More

Bioquell Donates BQ-50 Decontamination System to BUMBLEance – The Children’s National Ambulance Service

August 2018

Modular, lightweight and easy-to-use unit set to reduce vehicle deep clean times by more than 50% and provide safe, pathogen-free environment Bioquell (www.bioquell.com) – one of the leading global experts in reducing the risk of bio-contamination in the healthcare, life science and pharmaceutical markets – has donated an automated BQ-50 decontamination system to BUMBLEance – […]

Read More

Bioquell UK LTD to Highlight Suitability of “World First” Qube Aseptic Work Station for CAR-T, Gene and Cell Therapy

May 2018

BIOQUELL UK LTD TO HIGHLIGHT SUITABILITY OF ‘WORLD FIRST’ QUBE ASEPTIC WORK STATION FOR CAR-T, GENE AND CELL THERAPY The only isolator to offer built in Bioquell Hydrogen Peroxide Vapour technology for rapid decontamination, reduced risk and major cost benefits Bioquell UK Ltd – one of the leading global experts in reducing the risk of […]

Read More

Bioquell Shortlisted for UK Stock Market Award

May 2018

BIOQUELL SHORTLISTED FOR UK STOCK MARKET AWARD   Bioquell UK Ltd (www.bioquell.com; tel: +44 (0) 1264 835835) – one of the leading global experts in reducing the risk of bio-contamination in the life science, healthcare and pharmaceutical markets – has been shortlisted in the highly competitive Best Health Care & Pharmaceutical PLC category of the […]

Read More

Leading bioprocessing institute to use new Bioquell Qube aseptic workstation

August 2017

The latest generation isolator was installed at the National Institute for Bioprocessing Research and Training (NIBRT) based in Dublin, Ireland, this February. The Bioquell Qube, a flexible aseptic workstation, is now up and running to assist with continual professional development at this leading institute for the life sciences industry. From order to installation, it only […]

Read More

Bioquell Qube to Polish manufacturing site

August 2017

The Polish subsidiary of a major international generics and specialty pharmaceutical manufacturer has chosen a Bioquell Qube M-11 system to provide the ideal environment for carrying out its product sterility testing. Previously, the quality department had been performing sterility testing utilising a laminar flow system and cleanroom for product protection.  The critical nature of such testing and the […]

Read More

Optimising the Biodecontamination process to minimise production downtime

August 2017

A multi-national vaccine manufacturer approached Bioquell in order to perform a Biodecontamination within its FDA approved facility. The facility itself, some 5,500 cubic meters, was treated as a single Biodecontamination enclosure with the entire process completed within 30 hours. After a successful deployment of the project,the customer contacted Bioquell wishing to establish an industry leading […]

Read More
Tags
All
<< 1 2

Sales and Technical Support & General Enquiries: +44 (0)1264 835 835

52 Royce Cl, Andover SP10 3TS, UK

enquiries@bioquell.com

  • © Bioquell UK Ltd 2019 All Rights Reserved
  • Privacy Policy
  • Terms of Use
Download PDF